GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

NEO-811   Click here for help

GtoPdb Ligand ID: 14486

Synonyms: compound I-123 [WO2025097090] | NEO811
Compound class: Synthetic organic
Comment: NEO-811 is a CRBN-mediated molecular glue degrader of aryl hydrocarbon nuclear translocator (ARNT; HIF-1β). ARNT is the obligate dimerization partner for the HIF-1α and HIF-2α transcriprion factors. Selective ARNT degradation therefore disrupts the expression of hypoxia-inducible genes such as those for cyclin D and VEGF proteins.
The chemical structure for NEO-811 is claimed in patent WO2025097090A1 [1].
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 115.95
Molecular weight 543.59
XLogP 0.08
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES CC1(C)CN(CC[C@@]1(C2=C(C3=CC(=CN=C3C=C2)C4CCC(=O)NC4=O)F)O)CC5=CC=C(C=C5)C6=NOC=N6
Isomeric SMILES CC1(C)CN(CC2=CC=C(C=C2)C3=NOC=N3)CC[C@]1(O)C4=C(F)C5=C(C=C4)N=CC(=C5)C6CCC(=O)NC6=O
InChI InChI=1S/C30H30FN5O4/c1-29(2)16-36(15-18-3-5-19(6-4-18)27-33-17-40-35-27)12-11-30(29,39)23-8-9-24-22(26(23)31)13-20(14-32-24)21-7-10-25(37)34-28(21)38/h3-6,8-9,13-14,17,21,39H,7,10-12,15-16H2,1-2H3,(H,34,37,38)/t21?,30-/m0/s1
InChI Key OFTSSWWYMRYXIM-LOGQOBJBSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
Bioactivity Comments
DC50 is <0.20 pM, and Dmax is >60% [1].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
aryl hydrocarbon receptor nuclear translocator Hs None Binding - - -
⤷ Molecular glue degrader
Targets where the ligand is described in the comment field
Target Comment
aryl hydrocarbon receptor nuclear translocator The ARNT protein (also known as HIF-1β) is the obligate dimerization partner for the HIF-1α and HIF-2α transcriprion factors. It is being investigated as a novel oncology drug target, with the development of targeted protein degraders in progress [2]. NEO-811 [1] is a clinical stage ARNT-selective degrader.